BioSpace News Archive

Replimune Group Inc. announced that Philip Astley-Sparke, Executive Chairman and Director of Replimune, will present and host investor meetings at the Piper Jaffray 31st Annual Healthcare Conference being held at the Lotte New York Palace in New York, NY.

CGuard™ EPS clinical data featured as a prominent discussion point in multiple key presentations

Global Blood Therapeutics, Inc. announced that it will present at the following investor conferences in December 2019.

Molecular Templates, Inc. announced that Eric Poma, Ph.D., Chief Executive Officer and Chief Scientific Officer, will present a corporate overview at the Evercore ISI HealthCONx Conference, and the Piper Jaffray 31st Annual Healthcare Conference.

Cabaletta Bio, Inc. announced that Steven Nichtberger, M.D., Chief Executive Officer and Co-founder, will present at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019, at 9:50 a.m. EST.

Surface Oncology announced that Jeff Goater, chief executive officer, and Vito Palombella, Ph.D., chief scientific officer, will participate in a fireside chat at the Evercore ISI 2nd Annual HealthCONx Conference.

Tetra Natural Health a wholly owned subsidiary of Tetra Bio-Pharma Inc., announced that it has submitted two over-the-counter DIN applications to Health Canada.

Kane Biotech Inc., a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, announced that that it has engaged Kilmer Lucas Inc. to provide the Company with select U.S. and Canadian investor relations and strategic advisory services..

resTORbio, Inc. announced that management will present at two upcoming investor conferences

Combination of Prexigebersen and Decitabine Showed Encouraging Safety and Efficacy Results